The need for continued development of ricin countermeasures
- PMID: 22536516
- PMCID: PMC3318197
- DOI: 10.1155/2012/149737
The need for continued development of ricin countermeasures
Abstract
Ricin toxin, an extremely potent and heat-stable toxin produced from the bean of the ubiquitous Ricinus communis (castor bean plant), has been categorized by the US Centers for Disease Control and Prevention (CDC) as a category B biothreat agent that is moderately easy to disseminate. Ricin has the potential to be used as an agent of biological warfare and bioterrorism. Therefore, there is a critical need for continued development of ricin countermeasures. A safe and effective prophylactic vaccine against ricin that was FDA approved for "at risk" individuals would be an important first step in assuring the availability of medical countermeasures against ricin.
References
-
- Balint GA. Ricin: the toxic protein of castor oil seeds. Toxicology. 1974;2(1):77–102. - PubMed
-
- Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response. Morbidity and Mortality Weekly Report. 2000;49(RR-4):1–14. - PubMed
-
- Cookson J, Nottingham J. A Survey of Chemical and Biological Warfare. Vol. 6. New York, NY, USA: Monthly Review Press; 1969.
-
- Poli MA, Roy C, Huebner KD, Franz DR, Jaax NK. Ricin. In: Dembek ZF, editor. Medical Aspects of Biological Warfare. Washington, DC, USA: Borden Institute; 2007. pp. 323–335.
-
- Audi J, Belson M, Patel M, Schier J, Osterloh J. Ricin poisoning a comprehensive review. Journal of the American Medical Association. 2005;294(18):2342–2351. - PubMed
LinkOut - more resources
Full Text Sources